tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Financial Statements

Compare
7 Followers

Basilea Pharmaceutica Financial Overview

Basilea Pharmaceutica's market cap is currently CHF672.46M. The company's EPS TTM is CHF1.637; its P/E ratio is 16.83; Basilea Pharmaceutica is scheduled to report earnings on February 17, 2026, and the estimated EPS forecast is CHF2.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueCHF 232.40MCHF 208.54MCHF 157.63MCHF 147.76MCHF 148.12M
Gross ProfitCHF 193.10MCHF 169.86MCHF 130.84MCHF 120.96MCHF 124.05M
Operating IncomeCHF 51.60MCHF 61.18MCHF 19.20MCHF 18.54MCHF 1.19M
EBITDACHF 51.60MCHF 63.13MCHF 23.18MCHF 26.21MCHF 6.72M
Net IncomeCHF 40.20MCHF 77.59MCHF 10.45MCHF 12.15MCHF -6.83M
Balance Sheet
Cash & Short-Term InvestmentsCHF 162.34MCHF 120.71MCHF 59.90MCHF 84.70MCHF 148.70M
Total AssetsCHF 282.00MCHF 257.76MCHF 173.29MCHF 220.85MCHF 247.27M
Total DebtCHF 100.93MCHF 111.67MCHF 128.61MCHF 187.14MCHF 218.96M
Net DebtCHF 71.29MCHF -9.03MCHF 68.71MCHF 150.57MCHF 164.00M
Total LiabilitiesCHF 154.06MCHF 176.76MCHF 183.29MCHF 241.56MCHF 305.87M
Stockholders' EquityCHF 127.94MCHF 81.00MCHF -10.00MCHF -20.71MCHF -58.61M
Cash Flow
Free Cash FlowCHF 59.47MCHF 72.65MCHF 13.21MCHF 3.75MCHF -32.88M
Operating Cash FlowCHF 62.09MCHF 74.36MCHF 14.24MCHF 7.06MCHF -32.02M
Investing Cash FlowCHF -2.86MCHF -1.01MCHF -1.03MCHF 91.65MCHF 3.58M
Financing Cash FlowCHF -21.43MCHF -13.16MCHF -57.30MCHF -45.25MCHF 16.64M
Currency in CHF

Basilea Pharmaceutica Earnings and Revenue History

Basilea Pharmaceutica Debt to Assets

Basilea Pharmaceutica Cash Flow

Basilea Pharmaceutica Forecast EPS vs Actual EPS